找回密碼
 To register

QQ登錄

只需一步，快速開始

掃一掃，訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Suffrage and Its Legacy in the Nordics and Beyond; Gender, Institutiona Josefina Erikson,Lenita Freidenvall Book 2024 The Editor(s) (if app

[復(fù)制鏈接]
查看: 54909|回復(fù): 47
樓主
發(fā)表于 2025-3-21 16:19:47 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Suffrage and Its Legacy in the Nordics and Beyond
副標(biāo)題Gender, Institutiona
編輯Josefina Erikson,Lenita Freidenvall
視頻videohttp://file.papertrans.cn/882/881623/881623.mp4
概述Combines historical and contemporary political science perspectives.Addresses the challenges for women’s political inclusion empirically and theoretically.Theorize on the ways in which political gende
叢書名稱Gender and Politics
圖書封面Titlebook: Suffrage and Its Legacy in the Nordics and Beyond; Gender, Institutiona Josefina Erikson,Lenita Freidenvall Book 2024 The Editor(s) (if app
描述.This book reflects on the centennial of women‘s suffrage?in the Nordic region and beyond, by exploring its relevance to political gender equality today and the conditions for feminist institutional change.?The book brings together historians and political scientists to provide a long-term historical perspective that lays the groundwork for theoretical development. In this regard, the book makes two key contributions: it furthers our understanding of different types of gendered institutional constraints on women’s political inclusion and elaborates feminist institutional strategies to counter these constraints..
出版日期Book 2024
關(guān)鍵詞Gender Equality; Political Participation; Political Representation; Suffrage; Institutions
版次1
doihttps://doi.org/10.1007/978-3-031-52359-5
isbn_softcover978-3-031-52361-8
isbn_ebook978-3-031-52359-5Series ISSN 2662-5814 Series E-ISSN 2662-5822
issn_series 2662-5814
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Suffrage and Its Legacy in the Nordics and Beyond影響因子(影響力)




書目名稱Suffrage and Its Legacy in the Nordics and Beyond影響因子(影響力)學(xué)科排名




書目名稱Suffrage and Its Legacy in the Nordics and Beyond網(wǎng)絡(luò)公開度




書目名稱Suffrage and Its Legacy in the Nordics and Beyond網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Suffrage and Its Legacy in the Nordics and Beyond被引頻次




書目名稱Suffrage and Its Legacy in the Nordics and Beyond被引頻次學(xué)科排名




書目名稱Suffrage and Its Legacy in the Nordics and Beyond年度引用




書目名稱Suffrage and Its Legacy in the Nordics and Beyond年度引用學(xué)科排名




書目名稱Suffrage and Its Legacy in the Nordics and Beyond讀者反饋




書目名稱Suffrage and Its Legacy in the Nordics and Beyond讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics
 

0票 0%

Better Implies Difficulty
 

0票 0%

Good and Satisfactory
 

0票 0%

Adverse Performance
 

0票 0%

Disdainful Garbage
您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:04:43 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:28:05 | 只看該作者
Josefina Erikson,Lenita Freidenvalls have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection.
地板
發(fā)表于 2025-3-22 05:50:26 | 只看該作者
s have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection.
5#
發(fā)表于 2025-3-22 11:21:06 | 只看該作者
P?l Brunnstr?m,Magnus Olofssonped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The conse
6#
發(fā)表于 2025-3-22 15:07:03 | 只看該作者
7#
發(fā)表于 2025-3-22 17:30:59 | 只看該作者
8#
發(fā)表于 2025-3-22 23:19:19 | 只看該作者
s of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agent
9#
發(fā)表于 2025-3-23 02:09:21 | 只看該作者
10#
發(fā)表于 2025-3-23 05:50:21 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-18 18:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
崇文区| 宜阳县| 北碚区| 大厂| 池州市| 黄石市| 绥芬河市| 逊克县| 武清区| 达孜县| 湖口县| 鹤峰县| 略阳县| 南城县| 南投市| 祁东县| 丰台区| 朝阳县| 原阳县| 皋兰县| 左权县| 枣阳市| 堆龙德庆县| 保靖县| 丹寨县| 山东| 姜堰市| 英吉沙县| 施甸县| 明溪县| 承德县| 广安市| 疏附县| 徐州市| 宜州市| 株洲县| 天峨县| 湛江市| 德保县| 南宁市| 雷山县|